Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Stifel, Cytokinetics
Cytokinetics started at buy by Stifel, aficamten highlighted
Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming catalysts. Read more here.
Stifel Initiates Coverage of Cytokinetics (CYTK) with Buy Recommendation
Fintel reports that on January 22, 2025, Stifel initiated coverage of Cytokinetics (NasdaqGS:CYTK) with a Buy recommendation. Analyst Price Forecast Suggests 85.04% Upside As of December 23, 2024, the average one-year price target for Cytokinetics is $84.
Stifel starts Cytokinetics stock with Buy, $80 target
Stifel analysts initiated coverage on Cytokinetics shares (NASDAQ:CYTK), assigning a Buy rating and setting a price target of $80.00. The new coverage comes after a period of instability for the company,
17h
on MSN
Stifel cuts EA stock price target to $133 after guidance slash
Stifel analysts responded to Electronic Arts' (NASDAQ:EA) pre-announced fiscal third-quarter 2025 results by lowering the ...
13h
New Fortress Energy price target raised to $23 from $17 at Stifel
Stifel raised the firm’s price target on New Fortress Energy (NFE) to $23 from $17 and keeps a Buy rating on the shares. The firm notes that on ...
20h
Quanta Services price target raised to $388 from $374 at Stifel
Stifel analyst Brian Brophy raised the firm’s price target on Quanta Services (PWR) to $388 from $374 and keeps a Buy rating ...
12h
on MSN
Stifel raises New Fortress Energy stock target to $23
Stifel analysts increased their price target on New Fortress Energy shares (NASDAQ:NFE) to $23.00, up from the previous $17.00, while reiterating a Buy rating on the stock. According to InvestingPro ...
20h
Old Dominion price target raised to $193 from $176 at Stifel
Stifel raised the firm’s price target on Old Dominion (ODFL) to $193 from $176 and keeps a Hold rating on the shares. 2024 largely proved to be ...
2d
Fastenal price target lowered to $82 from $86 at Stifel
Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...
8d
Canada’s Eight Capital to Shut Down as Stifel Swoops In for Bankers
Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.
1d
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...
24/7 Wall St
2d
2025 Bull Market: Here's How High These Wall Street Analysts Think the Market Could Go In 2025
Wall Street analysts are buzzing with optimism as we step into 2025. There are plenty of reasons for a positive view to ...
Legal Sports Report
6d
Stifel Initiates FanDuel Parent Flutter With Buy Rating
Stifel initiated coverage of FanDuel parent company Flutter Thursday with a $320 target price and a buy rating.
13d
What Analysts Are Saying About Stifel Financial Stock
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...
1d
Edgewise rated as a new Hold at Stifel on a balanced risk-reward setup
Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Trade
Electronic Arts
NASDAQ
New Fortress Energy
Vulnerability management
Feedback